Lexicon Pharmaceuticals (LXRX) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of$0.07. This compares to a loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +42.86$0.08 per share when it actually produced earnings of $0.01, delivering a surprise of +112.5%.Over the last four quarters, the comp ...